Literature DB >> 15886091

Viral immunity: cross-priming with the help of TLR3.

Mariolina Salio1, Vincenzo Cerundolo.   

Abstract

Cross-presentation is important for regulating T-cell responses to exogenous antigens and can maintain tolerance (cross-tolerance) or induce immune responses (cross-priming). Recent exciting results on the role of the Toll-like receptor TLR3 in promoting cross-priming of viral antigens provide new insights into the mechanisms that allow Toll-like receptor signaling to bridge innate and adaptive immune responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15886091     DOI: 10.1016/j.cub.2005.04.025

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  12 in total

Review 1.  Toll-like receptors and leishmaniasis.

Authors:  Felipe F Tuon; Valdir S Amato; Hélio A Bacha; Tariq Almusawi; Maria I Duarte; Vicente Amato Neto
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

2.  Toll-like receptor 3 regulates Mx expression in rare minnow Gobiocypris rarus after viral infection.

Authors:  Jianguo Su; Zuoyan Zhu; Yaping Wang; Jun Zou; Wei Hu
Journal:  Immunogenetics       Date:  2008-03-28       Impact factor: 2.846

3.  Critical role of IRF-8 in negative regulation of TLR3 expression by Src homology 2 domain-containing protein tyrosine phosphatase-2 activity in human myeloid dendritic cells.

Authors:  Alessandra Fragale; Emilia Stellacci; Ramona Ilari; Anna Lisa Remoli; Angela Lanciotti; Edvige Perrotti; Iart Shytaj; Roberto Orsatti; Harshani R Lawrence; Nicholas J Lawrence; Jerry Wu; Michael Rehli; Keiko Ozato; Angela Battistini
Journal:  J Immunol       Date:  2011-01-10       Impact factor: 5.422

4.  Learning from viruses: the necrotic bodies of tumor cells with intracellular synthetic dsRNA induced strong anti-tumor immune responses.

Authors:  Zhengrong Cui; Uyen M Le; Fu Qiu; Dalia S Shaker
Journal:  Pharm Res       Date:  2007-04-03       Impact factor: 4.200

5.  TLR3 and TLR4 are innate antiviral immune receptors in human microglia: role of IRF3 in modulating antiviral and inflammatory response in the CNS.

Authors:  Hyeon-Sook Suh; Meng-Liang Zhao; Namjong Choi; Thomas J Belbin; Celia F Brosnan; Sunhee C Lee
Journal:  Virology       Date:  2009-07-30       Impact factor: 3.616

6.  Localized irradiation of tumors prior to synthetic dsRNA therapy enhanced the resultant anti-tumor activity.

Authors:  Uyen M Le; Darryl G L Kaurin; Brian R Sloat; Nijaporn Yanasarn; Zhengrong Cui
Journal:  Radiother Oncol       Date:  2008-11-14       Impact factor: 6.280

7.  Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC.

Authors:  Eva Lion; Sébastien Anguille; Zwi N Berneman; Evelien L J M Smits; Viggo F I Van Tendeloo
Journal:  PLoS One       Date:  2011-06-17       Impact factor: 3.240

Review 8.  Showing the Way: Oncolytic Adenoviruses as Chaperones of Immunostimulatory Adjuncts.

Authors:  Jing Li Huang; Christopher J LaRocca; Masato Yamamoto
Journal:  Biomedicines       Date:  2016-09-19

Review 9.  PAMPs and DAMPs: signal 0s that spur autophagy and immunity.

Authors:  Daolin Tang; Rui Kang; Carolyn B Coyne; Herbert J Zeh; Michael T Lotze
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

Review 10.  Trial watch: TLR3 agonists in cancer therapy.

Authors:  Julie Le Naour; Lorenzo Galluzzi; Laurence Zitvogel; Guido Kroemer; Erika Vacchelli
Journal:  Oncoimmunology       Date:  2020-06-02       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.